Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lorenzo Gubian, Angelo Avogaro, Gian Paolo Fadini
- ISSN / E-ISSN
- — / —
- DOI
- 10.1136/bmjdrc-2020-001451 ↗
- Volume · Issue · Pages
- 8 · 1 · e001451-e001451
- Publisher
- BMJ Publishing Group
- Article URL
- https://doi.org/10.1136/bmjdrc-2020-001451 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jun 2020
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jun 2020 | OpenAlex |
Keywords (as given): type 2 diabetes; SGLT2 inhibitors; GLP-1 receptor agonists; cardiovascular outcomes; major adverse cardiovascular events; myocardial infarction; stroke; heart failure hospitalization; revascularization; real-world evidence; comparative effectiveness; antidiabetic drugs; adverse events; propensity score matching; northeastern Italy; Italy; North America; Europe; North Africa; South America
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- BMJ Open Diabetes Research and Care
- Publication date used
- 01 Jun 2020 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.